MP Advisors started worldwide coverage of the Bio-Pharmaceutical industry in the mid 90s and has witnessed the rise and fall of many large cap and biotech companies. This experience of watching and surviving many Wall Street crisis has taught our analyst team to identify the real value creators vs. those who play to the gallery. Most of our team members have prior experience of working in pharma companies and therefore each one of them brings a first hand knowledge and right contacts with industry executives to make our work different from the street. We work in collaboration with our clients and regularly conduct special projects, including deep-dive assessments of specific opportunities. We are independent thinkers — not broker/dealers.